IRCT20230903059342N2招募中1 期
Phase 1 Clinical Trials of Intraperitoneal Measles Virotherapy in Patients With Ovarian Cancer
Kian Gen Azma Company0 个研究点目标入组 15 人开始时间: 待定最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 70 years（—）
- 性别
- Female
入选标准
- •Confirmation of the patient's ovarian cancer by a gynecologist
- •Diagnosis of disease as drug resistance
- •Patient age 18 to 70
- •Absence of pregnancy.
- •The Karnofsky performance score (KPS) of the patient is more than 50% (the patient is not disabled and does not need special assistance and care).
- •The ability to understand and sign the consent form by the patient and one of these cases: the patient's spouse, parent or guardian.
- •Proper functioning of liver, kidney and bone marrow
- •Complying with all protocol steps including sample submission and returning to the clinical study site for subsequent visits
- •Absence of autoimmune diseases or diseases of the immune system
排除标准
- •Life-threatening acute infection
- •Absence of any previous record that describes the doctor's treatment and orders were nor followed by patient.
- •Using drugs that weaken the immune system
- •Affected by any diseases that disturbs the immune system
- •Having any previous record of organ transplantation
- •Allergy to measles vaccine
- •Using other investigational treatments at the same time
- •Being effected by other cancers
研究者
相似试验
进行中（未招募）
1 期
MV-NIS Infected Mesenchymal Stem Cells in Treating Recurrent Ovarian, Primary Peritoneal or Fallopian Tube CancerFallopian Tube Clear Cell AdenocarcinomaFallopian Tube Endometrioid AdenocarcinomaFallopian Tube Mucinous AdenocarcinomaFallopian Tube Serous AdenocarcinomaFallopian Tube Transitional Cell CarcinomaFallopian Tube Undifferentiated CarcinomaMalignant Ovarian Brenner TumorOvarian Clear Cell AdenocarcinomaOvarian Endometrioid AdenocarcinomaOvarian Mucinous AdenocarcinomaOvarian Seromucinous CarcinomaOvarian Serous AdenocarcinomaOvarian Transitional Cell CarcinomaOvarian Undifferentiated CarcinomaPrimary Peritoneal Serous AdenocarcinomaRecurrent Fallopian Tube CarcinomaRecurrent Ovarian CarcinomaRecurrent Primary Peritoneal CarcinomaNCT02068794Mayo Clinic34
招募中
1 期
A phase 1 clinical trial of intraperitoneal administration of iCAR-ILC/N101 for ovarian clear cell carcinomaPatients with GPC3-expressing advanced ovarian clear cell carcinoma with peritoneal disseminationovarian clear cell carcinomaJPRN-jRCT2033200431Harano Kenichi18
招募中
1 期
Investigation of the safety and efficacy of the optimized measles virus vaccine in bladder tumor healingIRCT20230903059342N1Kian Gen Azma Company10
已完成
1 期
Intrapleural Measles Virus Therapy in Patients With Malignant Pleural MesotheliomaRecurrent Malignant MesotheliomaStage IA Malignant MesotheliomaStage IB Malignant MesotheliomaStage II Malignant MesotheliomaStage III Malignant MesotheliomaStage IV Malignant MesotheliomaNCT01503177Mayo Clinic15
尚未招募
1 期
A Vaccine for preventing PregnancyCTRI/2017/09/009934Indian Council of Medical Research